The live cell imaging market is driven by advancements in cell biology research, increasing demand for high-content screening ...
In a momentous move to recognize the world-changing impact that technology, engineering, and science innovators have on ...
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced the launch of ...
Biomaterials are revolutionizing organoid development by offering tunable platforms that provide instructive cues, which enhance cell fate transitions, tissue-level functions and reproducibility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback
